How long before Wegovy works — and what 'working' actually means

The decision you are probably weighing: is this going to take too long?

This is the question underneath most searches on this topic. You have seen trial numbers, perhaps heard a friend mention results, and you want to know whether the timeline is realistic for you, not for a study participant who was carefully monitored for 68 weeks. That is a completely fair thing to want answered before you commit.

The honest answer is that Wegovy works in two distinct phases, and conflating them causes most of the confusion. The first phase is appetite change, a quietening of hunger signals that many people notice surprisingly early, sometimes within days of the first 0.25 mg injection, more commonly by the end of the first or second week. The second phase is weight loss itself, which follows behind, usually becoming measurable on the scales from week four or five, and more visible to others from around weeks eight to twelve.

These two phases are linked but not identical. Semaglutide acts on GLP-1 receptors in the brain and gut, slowing gastric emptying and reducing appetite. That appetite shift can precede the weight change by weeks. If you want a fuller breakdown of how long until Wegovy works across both of these phases, that page walks through the timing in detail. If you are only measuring progress by the number on the scales in week one, you may underestimate how much is already happening.

The Wegovy treatment overview on our site covers the licensed dose schedule and eligibility in more detail if you want the broader picture first.

How the dose schedule shapes your progress over the first five months

Wegovy's titration ladder is not optional. Treatment starts at 0.25 mg weekly, moving to 0.5 mg, then 1.0 mg, then 1.7 mg, and finally 2.4 mg, spending roughly four weeks at each step. That puts most people at full maintenance dose around week 17. The newer 7.2 mg maximum dose, approved by the MHRA in January 2026 and with a dedicated single-dose pen approved in April 2026, is an extension beyond 2.4 mg for eligible adults, reached even later in treatment.

This schedule exists because slower titration dramatically reduces gastrointestinal side effects, the nausea and digestive discomfort that can accompany early treatment. It is not a delay for its own sake. The practical implication is that comparing your week-six progress against a friend's week-twenty progress is comparing apples to something entirely different.

Weight loss in the first weeks of Wegovy treatment tends to be modest (perhaps one to two kilograms) then accelerates once the maintenance dose is established. The STEP 1 trial, published in the New England Journal of Medicine, showed the steepest rate of loss between roughly weeks 16 and 36, before the curve began to flatten toward a plateau. That plateau is normal and expected, not a sign the medicine has stopped working.

One practical note on timing: if you are planning to start around a bank holiday or a period when you will be travelling, it is worth factoring that into your order schedule. Starting mid-cycle because of a holiday gap can make the first few weeks feel bumpier than they need to be. There is nothing medically wrong with that, it is just easier to settle into a weekly routine when the first few doses land predictably. If you are still weighing up how long till Wegovy works in practice, that page covers the dose-by-dose picture in plain language.

What the trial data says about results at different time points

The STEP 1 trial (68 weeks, nearly 2,000 adults without diabetes) is the foundational evidence for Wegovy's effectiveness at 2.4 mg. Average weight reduction was around 15% of body weight. That figure is an average across all participants, which means roughly half saw more and half saw less. Some participants lost 5% of body weight; others lost more than 20%.

At the higher 7.2 mg dose, trial data reported an average weight loss of approximately 20.7% over 72 weeks, approaching results previously associated only with tirzepatide. This is cited on the dedicated timeline page covering the longer arc of treatment.

NICE's appraisal of semaglutide (TA875) notes that treatment should be reviewed if less than 5% weight loss has occurred after six months at the maintenance dose. That six-month checkpoint is the clinical signal to reassess, not a rigid deadline at which the medicine is deemed to have failed. Some people respond more slowly and still achieve meaningful long-term results.

The NHS patient information page for semaglutide sets out what to expect during treatment and when to contact a prescriber, and is worth reading alongside any commercial information you encounter.

For context on how the semaglutide molecule itself behaves across both injection and tablet formulations, that page goes into the mechanism in more depth.

What affects how quickly Wegovy works for you specifically

Individual variation in response is real and clinically documented. Starting BMI, metabolic health, dietary habits alongside treatment, and how actively you adjust portion sizes in response to reduced appetite all influence the rate of loss. Semaglutide does not work in isolation, the licensed indication describes it as an adjunct to a reduced-calorie diet and increased activity, and that framing reflects genuine biology, not small print.

Gastrointestinal side effects during titration can also influence early results in either direction. Nausea that reduces appetite further sometimes accelerates early loss; but nausea that makes eating uncomfortable is not the mechanism the medicine is designed to use, and persistent symptoms should be discussed with your prescriber rather than managed by reducing food intake alone.

People who transfer to Wegovy from another GLP-1 medicine, or who restart after a break, may have a different early experience than someone starting from scratch. A prescriber who knows your history can set realistic expectations for your specific starting point.

If you are thinking about what supervised treatment could look like for you, our free consultation is the place to start, a GPhC-registered prescriber reads your answers the same day and can discuss what a realistic timeline looks like given your circumstances.